Literature DB >> 22507873

Is there any clinically relevant cannabinoid-induced analgesia?

Birgit Kraft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22507873     DOI： 10.1159/000337376

Source DB:  PubMed          Journal:  Pharmacology        ISSN： 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  19 in total

1.  Development of Water-Soluble Electrospun Fibers for the Oral Delivery of Cannabinoids.

Authors:  Eleftherios G Andriotis; Konstantina Chachlioutaki; Paraskevi Kyriaki Monou; Nikolaos Bouropoulos; Dimitrios Tzetzis; Panagiotis Barmpalexis; Ming-Wei Chang; Zeeshan Ahmad; Dimitrios G Fatouros
Journal:  AAPS PharmSciTech       Date:  2021-01-05       Impact factor: 3.246

2.  Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.

Authors:  David R Maguire; Wenjuan Yang; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2013-03-27       Impact factor: 4.030

3.  Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Christian A Kell; Ulrike Nöth; Johannes Vermehren; Jochen Kaiser; Ralf Deichmann; Jörn Lötsch
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

4.  Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Authors:  Laura Kranaster; Carolin Hoyer; Suna Su Aksay; Jan Malte Bumb; F Markus Leweke; Christoph Janke; Manfred Thiel; Beat Lutz; Laura Bindila; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-24       Impact factor: 5.270

5.  Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Authors:  Andrew J Kwilasz; Rehab A Abdullah; Justin L Poklis; Aron H Lichtman; Sidney S Negus
Journal:  Behav Pharmacol       Date:  2014-04       Impact factor: 2.293

6.  Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid.

Authors:  John Merrick; Brian Lane; Terri Sebree; Tony Yaksh; Carol O'Neill; Stan L Banks
Journal:  Cannabis Cannabinoid Res       Date:  2016-04-01

7.  Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Ulrike Nöth; Johannes Vermehren; Ralf Deichmann; Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2017-09-02       Impact factor: 2.953

8.  Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers.

Authors:  Carmen Walter; Bruno G Oertel; Dagmar Ludyga; Alfred Ultsch; Thomas Hummel; Jörn Lötsch
Journal:  Br J Clin Pharmacol       Date:  2014-11       Impact factor: 4.335

9.  Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.

Authors:  Ram Kandasamy; Cole T Dawson; Rebecca M Craft; Michael M Morgan
Journal:  Eur J Pharmacol       Date:  2017-10-28       Impact factor: 4.432

10.  Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Charles P France
Journal:  Behav Pharmacol       Date:  2012-12       Impact factor: 2.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.